Vaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of ...

It’s not yet certain which animals are the natural carriers. But, based on the available evidence, it is thought to be ...

Several African and ex-Soviet countries have expressed interest in buying Russia's vaccine against smallpox and mpox viruses, ...

Russia’s consumer and health watchdog told Reuters that several African and former Soviet countries had expressed interest in ...

KEMRI said in a statement issued in Nairobi, the capital of Kenya, that the Phase I clinical trial of TNX-801, an investigational vaccine designed to prevent mpox will take place in Kenya, focusing on ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon and welcome everyone to the GeoVax Third Quarter 2024 Corporate Update Call. My name is Michelle and I will facilitate today ...

The Frederick biotechnology company BioFactura has announced $7.8 million in new contract activations to study a treatment for a potential smallpox outbreak. The company has gotten contract option ...

Press Release - A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic ...

Russia's consumer and health watchdog told Reuters several African and ex-Soviet countries had expressed interest in buying ...

Mpox and Smallpox Vaccine Platform GEO-MVA is GeoVax’s vaccine candidate in development for protection against Mpox and Smallpox. A cGMP Master Seed Virus has been successfully manufactured and ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...